Search

Displaying results 7521 - 7530 of 10000 in total
  1. Drug

    Cargutocin

    go.drugbank.com/drugs/DB19643
    Experimental

    Cargutocin is a small molecule drug. Cargutocin has a monoisotopic molecular weight of 915.48 Da.

  2. Drug

    Terdecamycin

    go.drugbank.com/drugs/DB19720
    Experimental

    Terdecamycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Terdecamycin is a antibiotic, produced by Streptomyces strain. … Terdecamycin has a monoisotopic molecular weight of 585.31 Da.

  3. Drug

    Cyprolidol

    go.drugbank.com/drugs/DB19771
    Experimental

    Cyprolidol is a small molecule drug. Cyprolidol has a monoisotopic molecular weight of 301.15 Da.

  4. Drug

    Ancriviroc

    go.drugbank.com/drugs/DB19773
    Experimental

    Ancriviroc is a small molecule drug. The usage of the INN stem '-viroc' in the name indicates that Ancriviroc is a CCR5 (Chemokine CC motif receptor 5) receptor antagonist. … Ancriviroc has a monoisotopic molecular weight of 556.2 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Pamicogrel

    go.drugbank.com/drugs/DB19812
    Experimental

    Pamicogrel is a small molecule drug. Pamicogrel has a monoisotopic molecular weight of 448.15 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    Nobiprostolan

    go.drugbank.com/drugs/DB19814
    Experimental

    Nobiprostolan is a small molecule drug. Nobiprostolan has a monoisotopic molecular weight of 468.35 Da.

  7. Drug

    MIP-1095 I-131

    go.drugbank.com/drugs/DB14978
    Investigational

    MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

  8. Drug

    Martinostat

    go.drugbank.com/drugs/DB14979
    Investigational

    Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer).

  9. Drug

    Nomacopan

    go.drugbank.com/drugs/DB14991
    Investigational

    Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).

    Categories: Recombinant Protein Inhibitor of Complement Factor 5
  10. Drug

    Pegunigalsidase alfa

    go.drugbank.com/drugs/DB14992
    ApprovedInvestigational

    Pegunigalsidase alfa (PRX-102) is a recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease, a rare genetic disorder characterized … [A259347,A259352] In May 2023, the EMA granted marketing authorization to pegunigalsidase alfa in the European Union (EU) for the treatment of adult patients with Fabry disease.